Cargando...

Replication of clinical associations with 17-hydroxyprogesterone in preterm newborns

Nationally newborn screening programs use 17-hydroxyprogesterone (17-OHP) as the biomarker to detect the rare but potentially fatal inherited disease, congenital adrenal hyperplasia (CAH). However, this biomarker is highly variable with a high false positive rate of detection, particularly in neonat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ryckman, Kelli K, Cook, Daniel E, Berberich, Stanton L., Shchelochkov, Oleg A, Copeland, Sara, Berends, Susan K, Busch, Tamara, Dagle, John M, Murray, Jeffrey C
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3552557/
https://ncbi.nlm.nih.gov/pubmed/22768660
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!